Tuesday, January 6, 2009

What Do Rockefeller Center and Ranbaxy Have in Common?

Daiichi Sankyo's $3.84 billion write-down of its stake in Ranbaxy Laboratories harkens back to some other sour deals by Japanese buyers.
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)